It has been frenetic beginning of the Trump administration, with controversial and wide-reaching executive orders issued on a daily basis. But US device-industry groups have so far projected a calm and optimistic tone about prospects for the sector.
That is the certainly case for the Medical Device Manufacturers Association and its President and CEO Mark Leahey, who recently spoke to Medtech Insight about MDMA's priorities for 2017. The...
Permanent repeal of the device tax, which is currently under a two-year suspension, remains MDMA's top goal, and momentum is high toward achieving that as part of an Affordable Care...